Edition:
India

Sawai Pharmaceutical Co Ltd (4555.T)

4555.T on Tokyo Stock Exchange

4,975JPY
21 Jun 2018
Change (% chg)

¥-15 (-0.30%)
Prev Close
¥4,990
Open
¥5,030
Day's High
¥5,080
Day's Low
¥4,970
Volume
297,600
Avg. Vol
263,065
52-wk High
¥6,700
52-wk Low
¥4,560

Latest Key Developments (Source: Significant Developments)

Sawai Pharmaceutical completes sale of 20 pct stake in Upsher-Smith Laboratories
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - Sawai Pharmaceutical Co Ltd <4555.T> ::Says 20 percent stake in Upsher-Smith Laboratories LLC, which was wholly owned by co's unit SAWAI AMERICA, LLC, has been transferred to SUMITOMO CORP's wholly owned US-based unit Sumitomo Corporation of Americas, on Jan. 3.Transaction amount is $211 million (about 23.2 billion yen).  Full Article

SAWAI PHARMACEUTICAL says details of shares private placement
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - SAWAI PHARMACEUTICAL Co Ltd <4555.T> ::Says it plans to issue 900,000 million new shares at totaling 4.27 billion yen with subscription date on Dec. 25 and payment date on Dec. 26.  Full Article

Sawai Pharmaceutical says share prices
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Sawai Pharmaceutical Co Ltd <4555.T>:Says it will issue new shares via public offering, with the issue price of 4,947 yen per share (24.74 billion yen in total) and paid-in price of 4,743 yen per share (23.72 billion yen in total) .Says it will distribute shares via public offering, with paid-in price of 4,743 yen per share (4.74 billion yen in total).Says it will issue new shares via private placement, with paid-in price of 4,743 yen per share (up to 4.27 billion yen in total) .The previous plan was disclosed on Nov. 27 .  Full Article

Sawai Pharmaceutical to issue new shares and to distribute treasury common stock
Monday, 27 Nov 2017 

Nov 27(Reuters) - Sawai Pharmaceutical Co Ltd <4555.T>:Says it plans to issue 5 million new shares and to distribute 1 million shares of its treasury common stock through public offering .Says it plans to issue 900,000 new shares through private placement to SMBC Nikko Securities Inc., with subscription date on Dec. 25 and payment date on Dec. 26.Proceeds to be used for loan repayment .  Full Article

Sawai Pharmaceutical to sell 20 pct stake in SAWAI AMERICA for $211 mln
Monday, 13 Nov 2017 

Nov 13(Reuters) - Sawai Pharmaceutical Co Ltd <4555.T>:Says it plans to sell 20 percent stake in a wholly owned U.S.-based unit SAWAI AMERICA INC to Sumitomo Corporation of Americas, a wholly owned unit of SUMITOMO CORPORATION <<<8053.T>>>, for $211 million (23.2 billion yen).Transaction will be completed as of the end of March 2018.  Full Article

Upsher-Smith says parent co to manufacture migraine medication in Japan With AstraZeneca
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Upsher-Smith Laboratories LLC::Upsher-Smith Laboratories says co's parent Sawai Pharmaceutical entered agreement with AstraZeneca to manufacture & market migraine medication in Japan​.Upsher-Smith Laboratories​ - agreement is to ‍manufacture, market Zomig (zolmitriptan) Tablets 2.5 mg & Zomig (zolmitriptan) Rapid Melt (RM) Tablets 2.5 mg.Upsher-Smith Labs - ‍under agreement, Sawai expected to take manufacturing, marketing of Zomig​ products in Japan by mid-2018 from AstraZeneca K.K.  Full Article